297 related articles for article (PubMed ID: 28828629)
1. Interleukin 6 induces M2 macrophage differentiation by STAT3 activation that correlates with gastric cancer progression.
Fu XL; Duan W; Su CY; Mao FY; Lv YP; Teng YS; Yu PW; Zhuang Y; Zhao YL
Cancer Immunol Immunother; 2017 Dec; 66(12):1597-1608. PubMed ID: 28828629
[TBL] [Abstract][Full Text] [Related]
2. Induction of Pro-Inflammatory Response via Activated Macrophage-Mediated NF-κB and STAT3 Pathways in Gastric Cancer Cells.
Zhou Y; Xia L; Liu Q; Wang H; Lin J; Oyang L; Chen X; Luo X; Tan S; Tian Y; Su M; Wang Y; Chen P; Wu Y; Wang H; Liao Q
Cell Physiol Biochem; 2018; 47(4):1399-1410. PubMed ID: 29929193
[TBL] [Abstract][Full Text] [Related]
3. [Gastric cancer-derived mesenchymal stem cells regulate the M2 polarization of macrophages within gastric cancer microenvironment via JAK2/STAT3 signaling pathway].
Li W; Zhao SL; Zheng P; Shi PQ; Zhou Y; Zhang T; Huo J; Yang J
Zhonghua Zhong Liu Za Zhi; 2022 Jul; 44(7):728-736. PubMed ID: 35880339
[No Abstract] [Full Text] [Related]
4. Gastric cancer-derived mesenchymal stromal cells trigger M2 macrophage polarization that promotes metastasis and EMT in gastric cancer.
Li W; Zhang X; Wu F; Zhou Y; Bao Z; Li H; Zheng P; Zhao S
Cell Death Dis; 2019 Dec; 10(12):918. PubMed ID: 31801938
[TBL] [Abstract][Full Text] [Related]
5. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-23 promotes the migration and invasion of gastric cancer cells by inducing epithelial-to-mesenchymal transition via the STAT3 pathway.
Xu X; Yang C; Chen J; Liu J; Li P; Shi Y; Yu P
Biochem Biophys Res Commun; 2018 May; 499(2):273-278. PubMed ID: 29574157
[TBL] [Abstract][Full Text] [Related]
7. The cell-cell interaction between tumor-associated macrophages and small cell lung cancer cells is involved in tumor progression via STAT3 activation.
Iriki T; Ohnishi K; Fujiwara Y; Horlad H; Saito Y; Pan C; Ikeda K; Mori T; Suzuki M; Ichiyasu H; Kohrogi H; Takeya M; Komohara Y
Lung Cancer; 2017 Apr; 106():22-32. PubMed ID: 28285690
[TBL] [Abstract][Full Text] [Related]
8. Oleanolic acid inhibits macrophage differentiation into the M2 phenotype and glioblastoma cell proliferation by suppressing the activation of STAT3.
Fujiwara Y; Komohara Y; Kudo R; Tsurushima K; Ohnishi K; Ikeda T; Takeya M
Oncol Rep; 2011 Dec; 26(6):1533-7. PubMed ID: 21922144
[TBL] [Abstract][Full Text] [Related]
9. Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation.
Takaishi K; Komohara Y; Tashiro H; Ohtake H; Nakagawa T; Katabuchi H; Takeya M
Cancer Sci; 2010 Oct; 101(10):2128-36. PubMed ID: 20860602
[TBL] [Abstract][Full Text] [Related]
10. Tumor associated macrophages provide the survival resistance of tumor cells to hypoxic microenvironmental condition through IL-6 receptor-mediated signals.
Jeong SK; Kim JS; Lee CG; Park YS; Kim SD; Yoon SO; Han DH; Lee KY; Jeong MH; Jo WS
Immunobiology; 2017 Jan; 222(1):55-65. PubMed ID: 26705936
[TBL] [Abstract][Full Text] [Related]
11. Macrophages in Langerhans cell histiocytosis are differentiated toward M2 phenotype: their possible involvement in pathological processes.
Ohnishi K; Komohara Y; Sakashita N; Iyama K; Murayama T; Takeya M
Pathol Int; 2010 Jan; 60(1):27-34. PubMed ID: 20055949
[TBL] [Abstract][Full Text] [Related]
12. Co-culture of ovarian cancer stem-like cells with macrophages induced SKOV3 cells stemness via IL-8/STAT3 signaling.
Ning Y; Cui Y; Li X; Cao X; Chen A; Xu C; Cao J; Luo X
Biomed Pharmacother; 2018 Jul; 103():262-271. PubMed ID: 29656182
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer cell-derived interleukin-6 enhances the phagocytic capacity and migration of THP-1 cells.
Yeh KY; Wu TH; Wu TL
Cytokine; 2016 Mar; 79():82-9. PubMed ID: 26775116
[TBL] [Abstract][Full Text] [Related]
14. Gefitinib inhibits M2-like polarization of tumor-associated macrophages in Lewis lung cancer by targeting the STAT6 signaling pathway.
Tariq M; Zhang JQ; Liang GK; He QJ; Ding L; Yang B
Acta Pharmacol Sin; 2017 Nov; 38(11):1501-1511. PubMed ID: 29022575
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages induce PD-L1 expression in gastric cancer cells through IL-6 and TNF-ɑ signaling.
Ju X; Zhang H; Zhou Z; Chen M; Wang Q
Exp Cell Res; 2020 Nov; 396(2):112315. PubMed ID: 33031808
[TBL] [Abstract][Full Text] [Related]
16. Pyropia yezoensis glycoprotein promotes the M1 to M2 macrophage phenotypic switch via the STAT3 and STAT6 transcription factors.
Choi JW; Kwon MJ; Kim IH; Kim YM; Lee MK; Nam TJ
Int J Mol Med; 2016 Aug; 38(2):666-74. PubMed ID: 27353313
[TBL] [Abstract][Full Text] [Related]
17. Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma.
Hasita H; Komohara Y; Okabe H; Masuda T; Ohnishi K; Lei XF; Beppu T; Baba H; Takeya M
Cancer Sci; 2010 Aug; 101(8):1913-9. PubMed ID: 20545696
[TBL] [Abstract][Full Text] [Related]
18. M2 macrophage/microglial cells induce activation of Stat3 in primary central nervous system lymphoma.
Komohara Y; Horlad H; Ohnishi K; Ohta K; Makino K; Hondo H; Yamanaka R; Kajiwara K; Saito T; Kuratsu J; Takeya M
J Clin Exp Hematop; 2011; 51(2):93-9. PubMed ID: 22104307
[TBL] [Abstract][Full Text] [Related]
19. M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells.
Heusinkveld M; de Vos van Steenwijk PJ; Goedemans R; Ramwadhdoebe TH; Gorter A; Welters MJ; van Hall T; van der Burg SH
J Immunol; 2011 Aug; 187(3):1157-65. PubMed ID: 21709158
[TBL] [Abstract][Full Text] [Related]
20. M2 polarized macrophages induced by CSE promote proliferation, migration, and invasion of alveolar basal epithelial cells.
Fu X; Shi H; Qi Y; Zhang W; Dong P
Int Immunopharmacol; 2015 Sep; 28(1):666-74. PubMed ID: 26253658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
